Cargando…
Efficacy and safety of molnupiravir for COVID-19 patients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130682/ https://www.ncbi.nlm.nih.gov/pubmed/35649740 http://dx.doi.org/10.1016/j.ejim.2022.05.024 |
| _version_ | 1784713022351081472 |
|---|---|
| author | Fatima, Maurish Azeem, Saleha Saeed, Junaid Shahid, Abia Cheema, Huzaifa Ahmad |
| author_facet | Fatima, Maurish Azeem, Saleha Saeed, Junaid Shahid, Abia Cheema, Huzaifa Ahmad |
| author_sort | Fatima, Maurish |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9130682 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91306822022-05-25 Efficacy and safety of molnupiravir for COVID-19 patients Fatima, Maurish Azeem, Saleha Saeed, Junaid Shahid, Abia Cheema, Huzaifa Ahmad Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2022-08 2022-05-25 /pmc/articles/PMC9130682/ /pubmed/35649740 http://dx.doi.org/10.1016/j.ejim.2022.05.024 Text en © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Fatima, Maurish Azeem, Saleha Saeed, Junaid Shahid, Abia Cheema, Huzaifa Ahmad Efficacy and safety of molnupiravir for COVID-19 patients |
| title | Efficacy and safety of molnupiravir for COVID-19 patients |
| title_full | Efficacy and safety of molnupiravir for COVID-19 patients |
| title_fullStr | Efficacy and safety of molnupiravir for COVID-19 patients |
| title_full_unstemmed | Efficacy and safety of molnupiravir for COVID-19 patients |
| title_short | Efficacy and safety of molnupiravir for COVID-19 patients |
| title_sort | efficacy and safety of molnupiravir for covid-19 patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130682/ https://www.ncbi.nlm.nih.gov/pubmed/35649740 http://dx.doi.org/10.1016/j.ejim.2022.05.024 |
| work_keys_str_mv | AT fatimamaurish efficacyandsafetyofmolnupiravirforcovid19patients AT azeemsaleha efficacyandsafetyofmolnupiravirforcovid19patients AT saeedjunaid efficacyandsafetyofmolnupiravirforcovid19patients AT shahidabia efficacyandsafetyofmolnupiravirforcovid19patients AT cheemahuzaifaahmad efficacyandsafetyofmolnupiravirforcovid19patients AT efficacyandsafetyofmolnupiravirforcovid19patients |